AlzChem Group AG invests approx. EUR 11 million in the expansion of Creapure® capacities and precursors
Trostberg, August 9, 2021 – AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, is experiencing sustained high demand for its Creapure® product, the world’s purest creatine monohydrate, which is used as a dietary supplement in sports nutrition and more and more in vegan and vegetarian foods. Against this background, the company has decided to significantly increase its production capacity for creatine monohydrate and to take advantage of additional opportunities in the market by expanding its production facility for sodium sarcosinate, the precursor of creatine monohydrate. A total of approx. EUR 11 million is to be invested in both measures. Commissioning is planned in stages from the 2nd quarter of 2022.
“With the planned investments, we will achieve further profitable growth. We will take advantage of our strong position in the premium creatine segment of the sports and health market. Likewise, we will benefit noticeably from our unique position as the quality leader 'Made in Germany',” explains Andreas Niedermaier, CEO of AlzChem Group AG.
The sports and health market is a growth market that has grown significantly in recent years. Sports nutrition is increasingly expanding from competitive sports to users who focus on fitness and a healthy lifestyle. Accordingly, marketing activities for Creapure® are increasingly being extended to these users. At the same time, AlzChem is focusing on strategic partnerships, for example in Europe, in order to participate with Creapure® in the strong growth in the market for vegan and vegetarian foods.
About AlzChem
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, AlzChem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. AlzChem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of AlzChem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. AlzChem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
Contact
Sabine Sieber
Head of Investor Relations & Communications
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany